Comparison of the effect of two types of soft embryo transfer catheters PM Trans Set Mini CH3 and Kitazato on the results of IVF in infertile women

Comparison of the effect of two types of soft embryo transfer catheters PM Trans Set Mini CH3 and Kitazato on the results of IVF in infertile women: a single blind randomized clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201601049014N88

Enrollment

Registered

2016-01-17

Start date

2015-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility

Interventions

Intervention 1: Embryo transfer using soft catheter PM Trans Set Mini CH3. Intervention 2: Embryo transfer using soft catheter Kitazato.

Treatment - Devices

Embryo transfer using soft catheter PM Trans Set Mini CH3

Embryo transfer using soft catheter Kitazato

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: (a) age less than 40; (b) (having more than 3 fetuses; (c) having healthy uterine cavity. Exclusion criteria: (a) having high baseline FSH level; (b) having a history of difficult transfer; (c) having more than 6 times IVF cycle; (d) idiopathic infertility; (e) donated fetus; (f) frizzed fetus.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Assessing pregnancy. Timepoint: titer14 days after embryo transfer. Method of measurement: through measuring ßhcg.;Assessing pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: through transvaginal ultrasonography.	—

Secondary

Measure	Time frame
Assessing the need to Tenaculum. Timepoint: immediately after embryo transfer. Method of measurement: by checking presence of blood or mucous on the head of catheter.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Hasan Bahrami

Fatemieh Hospital

dr.hsn.bahrami@gmail.com+98 81 3828 3939

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026